Gait Adaptability: Tracking Locomotor Recovery After Incomplete Spinal Cord Injury
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03343132 |
|
Recruitment Status :
Recruiting
First Posted : November 17, 2017
Last Update Posted : August 4, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Gait Disorders, Neurologic Gait Disorder, Sensorimotor | Behavioral: Standard locomotor therapy |
| Study Type : | Observational |
| Estimated Enrollment : | 100 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Prospective |
| Official Title: | Gait Adaptability: Tracking Locomotor Recovery After Incomplete Spinal Cord Injury Via Sensitive Assessments in a Virtual Reality Treadmill Environment |
| Actual Study Start Date : | January 1, 2018 |
| Estimated Primary Completion Date : | December 31, 2021 |
| Estimated Study Completion Date : | December 31, 2021 |
| Group/Cohort | Intervention/treatment |
|---|---|
| Subacute SCI |
Behavioral: Standard locomotor therapy
Typical clinical therapy. |
| Chronic SCI | |
| Controls |
- Change in kinematics [ Time Frame: Baseline and through study completion, an average of 4 months ]Recording of movement tasks
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Informed Consent as documented by signature (Appendix Informed Consent Form)
- Healthy controls
- Patients with an incomplete spinal cord injury in a chronic (at least 12 months post-injury) or subacute (3-6 months post-injury) stage of recovery
- Age: 18 years and older
- Able to stand without physical assistance and handrails for more than 120s
- preserved segmental and cutaneo-muscular reflexes in the lower limbs
- Bodyweight over 20 kg and under 120 kg
- Mini-Mental state examination score 26 (test only performed if cognitive deficits are suspected)
Exclusion Criteria:
- Current orthopedic problems
- Neurological impairment other than SCI
- Premorbid major depression or psychosis
- Metal implants in the cervical skull
- History of significant autonomic dysreflexia with treatment
- Dermatological issues (e.g. decubitus) at the harness attachment site (back, abdomen, upper legs)
- Malignant diseases
- Heart insufficiency NYHA III-IV
- Potential pregnancy
- Unlikely to complete the intervention or return for follow-up
- Participation in another training study
- Contraindications for training using the GRAIL (according the manual)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03343132
| Contact: Armin Curt, Prof. | +41 44 386 39 01 | armin.curt@balgrist.ch |
| Switzerland | |
| Universitätsklinik Balgrist | Recruiting |
| Zürich, Switzerland, 8008 | |
| Contact: Freschta Mohammadzada +41 44 510 72 21 freschta.mohammadzada@balgrist.ch | |
| Contact: Charlotte Werner charlotte.werner@balgrist.ch | |
| Responsible Party: | University of Zurich |
| ClinicalTrials.gov Identifier: | NCT03343132 |
| Other Study ID Numbers: |
2017-01780 |
| First Posted: | November 17, 2017 Key Record Dates |
| Last Update Posted: | August 4, 2021 |
| Last Verified: | July 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Spinal Cord Injuries Nervous System Diseases Gait Disorders, Neurologic Disease Pathologic Processes |
Spinal Cord Diseases Central Nervous System Diseases Trauma, Nervous System Wounds and Injuries Neurologic Manifestations |

